AI in Radiomics Using Imaging Data to Predict Treatment Response Introduction Artificial Intelligence (AI) has emerged as a powerful tool in healthcare, advancing medical imaging and precision diagnostics. A particularly promising application is radiomics, a ...

AI in Radiomics Using Imaging Data to Predict Treatment Response
www.ekascloud.com/our-blog/ai-...
#Radiomics #AIinHealthcare #MedicalImaging #AIDiagnostics #TreatmentResponse #HealthcareInnovation #DeepLearning #PrecisionMedicine #MedicalAI #ImagingAnalytics #CancerImaging

Innovative treatment achieves complete long-term remission without surgery in 46 percent of advanced liver cancer patients – BioNews Central A study has shown that combined locoregional therapy and immunotherapy provides a safe, effective, and lasting treatment response for patients with advanced liver cancer, identifying key factors linked to complete response. ...

A study has shown that combined #LocoregionalTherapy and #immunotherapy provides a safe, effective, and lasting #TreatmentResponse for patients with #AdvancedLiverCancer, identifying key factors linked to #CompleteResponse.
#LiverCancer #LiverCancerTreatment #CombinationTherapy

Vanessa Schmidt has won the Werner J. Siebert Research Prize of the #DiGGefa e.V. for the project #CirculatingEndothelialCells as #Biomarker for #TreatmentResponse and Relapse in #ArteriovenousMalformations. 🎉 #LMUradiology

This study by Gigin Lin et al. shows that hyperpolarized [1-13C]-pyruvate MRI/MRS can assess immune activity in the spleen, helping identify potential candidates for radiotherapy in #CervicalCancer.

#RadiologyAndBeyond
#EuropeanRadiologyExperimental
#TreatmentResponse

🔗 https://buff.ly/3WM7mua

Intratumoral and peritumoral radiomics predict pathological response after neoadjuvant chemotherapy against advanced gastric cancer - Insights into Imaging Background To investigate whether intratumoral and peritumoral radiomics may predict pathological responses after neoadjuvant chemotherapy against advanced gastric cancer. Methods Clinical,…

The radiomics-clinical model outperformed individual models, offering a more accurate assessment and higher predictive efficiency. (Chenchen Liu et al.)

#RadiologyAndBeyond
#InsightsIntoImaging
#TreatmentResponse
#RadSky
#MedSky

🔗 https://buff.ly/3OnHbG5

Are radiologists ready to evaluate true response to immunotherapy? - Insights into Imaging Background Standardized response criteria for evaluating patients radiological imaging have an essential role in oncological management. Immunotherapy, using immune checkpoint inhibitors (ICIs),…

This Critical Review highlights the need for standardized response criteria, like immune-#RECIST, and calls for further research to optimize patient management in immunotherapy. (Inci Kizildag Yirgin et al.)

#RadiologyAndBeyond
#InsightsIntoImaging
#TreatmentResponse

🔗 https://buff.ly/3LlI5l0

CT features combined with RECIST 1.1 criteria improve progression assessments of sunitinib-treated gastrointestinal stromal tumors - European Radiology Objectives To explore the auxiliary value of combining CT features with existing response evaluation criteria in the prediction of progressive disease (PD) in gastrointestinal stromal tumors (GIST)…

The new mRECIST model outperforms traditional methods, offering a more accurate tool for early disease prediction. (Jiazheng Li et al.)

#RadiologyAndBeyond
#EuropeanRadiology
#TreatmentResponse
#RadSky

🔗 https://buff.ly/3NwhC5o

Assessment of hepatocellular carcinoma treatment response with LI-RADS: a pictorial review - Insights into Imaging Computed tomography (CT) and magnetic resonance imaging (MRI) play critical roles for assessing treatment response of hepatocellular carcinoma (HCC) after locoregional therapy. Interpretation is…

It provides standardized categories like Nonviable, Viable, Nonevaluable, and Equivocal, aiding clear and consistent reporting. (Nicolas Voizard et al.)

#RadiologyAndBeyond
#InsightsIntoImaging
#TreatmentResponse
#RadSky

🔗 https://buff.ly/3Uzrxtm

Real-world response assessment of immune checkpoint inhibition: comparing iRECIST and RECIST 1.1 in melanoma and non-small cell lung cancer patients - European Radiology Objectives To compare immune response evaluation criteria in solid tumors (iRECIST) and response evaluation criteria in solid tumors (RECIST) 1.1 for response assessment of immune checkpoint…

They showed that iRECIST better captured atypical response patterns to ICI therapy, with higher overall response and disease control rates and longer time to progression.

#RadiologyAndBeyond
#EuropeanRadiology
#TreatmentResponse
#RadSky

🔗 https://buff.ly/3N93G0p

A European Society of Oncologic Imaging (ESOI) survey on the radiological assessment of response to oncologic treatments in clinical practice - Insights into Imaging Objectives To present the results of a survey on the assessment of treatment response with imaging in oncologic patient, in routine clinical practice. The survey was promoted by the European Society…

...but there's a need for more standardized, generally applicable reporting rules to guide response assessment in clinical practice. (Giovanni Cappello et al.)

#RadiologyAndBeyond
#InsightsIntoImaging
#TreatmentResponse
#RadSky

🔗 https://buff.ly/3H9Iog0

ESR Essentials: response assessment criteria in oncologic imaging—practice recommendations by the European Society of Oncologic Imaging - European Radiology Abstract Assessing the response to oncological treatments is paramount for determining the prognosis and defining the best treatment for each patient. Several biomarkers, including imaging, can be…

These guidelines may be helpful when applied to clinical practice for day-to-day interpretation. (Giulia A. Zamboni et al.)

#RadiologyAndBeyond
#EuropeanRadiology
#TreatmentResponse
#RadSky

🔗 https://buff.ly/47eJAeh

Excellent discussion paper on #rct #evaluation #casestudies #doseresponse #treatmentresponse #personalizedmedicine